Yamamoto J, Murata T, Sugisawa N, Higuchi T, et al. Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model. Anticancer Res 2020;40:2475-2479.
PMID: 32366391